Which hedge funds own APGE? APOGEE THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
13 of the hedge funds tracked by WhaleCreep disclosed a position in APGE (APOGEE THERAPEUTICS INC) in their Q2 2026 13F filings, worth $632.2m in total. The largest holder by portfolio weight is Pentwater Capital Management at 1.5% of its book. 7 managers opened a new position this quarter: Pentwater Capital Management, Melqart, Soros Fund Management, Moore Capital Management. 1 exited: Holocene Advisors.
13tracked managers holding
7opened this quarter
1exited this quarter
Which hedge funds hold APGE? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Pentwater Capital Management | Q2 2026 | 1.5% | $189.1m | 1,425,000 | – | new |
| Melqart | Q2 2026 | 1.5% | $15.6m | 117,249 | – | new |
| Soros Fund Management | Q2 2026 | 1.0% | $74.9m | 564,500 | – | new |
| Woodline Partners | Q2 2026 | 0.2% | $61.7m | 464,622 | 78% | added |
| Millennium Management | Q2 2026 | 0.1% | $198.0m | 1,491,404 | 1511% | added |
| Moore Capital Management | Q2 2026 | 0.1% | $2.7m | 20,000 | – | new |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $19.5m | 146,800 | – | new |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $32.7m | 246,086 | 318% | added |
| Tudor Investment | Q2 2026 | 0.0% | $4.7m | 35,734 | – | new |
| WCM Investment Management | Q2 2026 | 0.0% | $10.1m | 75,974 | -0% | held |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $7.2m | 54,559 | – | new |
| Marshall Wace | Q2 2026 | 0.0% | $10.3m | 77,475 | -3% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $5.8m | 43,857 | -93% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Holocene Advisors | 0.1% | $4.8m |
How has hedge fund ownership of APGE changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 13 | $632.2m |
| Q1 2026 | 7 | $102.7m |
| Q4 2025 | 2 | $18.2m |
| Q3 2025 | 1 | $2.3m |
| Q2 2025 | 4 | $95.8m |
| Q1 2025 | 3 | $112.9m |
| Q4 2024 | 3 | $130.8m |
| Q3 2024 | 4 | $223.2m |
| Q2 2024 | 5 | $142.5m |
| Q1 2024 | 7 | $263.1m |
| Q4 2023 | 4 | $87.0m |
| Q3 2023 | 5 | $59.1m |
Counts every tracked manager that disclosed APGE in that quarter's filing, including managers that have since stopped filing.